Advertisement

Topics

Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug

22:53 EDT 29 Jun 2017 | Xconomy

The early results are in for a Phase 3 clinical trial testing Alkermes’ schizophrenia drug, and the company’s drug worked just as well as a medication already used to treat the psychiatric condition. But so far, it hasn’t distinguished itself on the side effect profile. Weight gain is a common side effect of psychiatric medications, […]

Original Article: Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug

NEXT ARTICLE

More From BioPortfolio on "Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...